Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors

Pengfei Fana Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China

Xiangyang Chia Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Guodong Liub Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, CanadaView further author information

Guanying Zhanga Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Zhengshan Chena Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Yujiao Liua Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Ting Fanga Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Jianmin Lia Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Logan Banadygab Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, CanadaView further author information

Shihua Heb Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, CanadaView further author information

Changming Yua Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaView further author information

Xiangguo Qiub Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, CanadaView further author information

Wei Chena Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, ChinaCorrespondence[email protected]
View further author information

Articles from other publishers (14)